Foundry Partners, LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 120 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$67,000
-10.7%
10,600
-40.7%
0.00%0.0%
Q2 2016$75,000
-3.8%
17,8750.0%0.00%
-50.0%
Q1 2016$78,000–17,875–0.01%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders